Impaired Glucose Metabolism in Women with Polycystic Ovary Syndrome

被引:11
作者
Vrbikova, Jana [1 ]
Fanta, Michal [2 ]
Cibula, David [2 ]
Vondra, Karel [1 ]
Bendlova, Bela [1 ]
机构
[1] Res Inst Endocrinol, CZ-11694 Prague 1, Czech Republic
[2] Charles Univ Prague, Gen Fac Hosp, Dept Obstet & Gynecol, Prague, Czech Republic
关键词
Diabetes mellitus; Impaired glucose tolerance; Polycystic ovary syndrome; TYPE-2; DIABETES-MELLITUS; INSULIN-RESISTANCE; FAMILY-HISTORY; UNITED-STATES; RISK-FACTORS; WEIGHT-GAIN; PREVALENCE; TOLERANCE; INTOLERANCE; OBESITY;
D O I
10.1159/000232574
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Background: To compare the prevalence of impaired glucose tolerance (IGT) and type 2 diabetes mellitus (T2DM) in lean and overweight/obese women with polycystic ovary syndrome (PCOS), with the data from a normal population sample. Methods: PCOS-affected women fulfilling ESHRE diagnostic criteria underwent an oral glucose tolerance test. Prevalence of IGT and T2DM in control sample of white healthy females was extracted from the published data from NHANES II. Results: In 225 women with PCOS, IGT was present in 6/104 (5.8%) lean and in 15/121 (12.4%) overweight/obese women. T2DM was present in 1/104 (1.0%) lean and in 3/121 (2.5%) overweight/obese PCOS women. In a sample of 643 women from NHANES II, the crude rate of IGT was 5.9%. IGT was significantly more common only in the overweight/obese PCOS subgroup as compared to the NHANES II cohort (chi(2) = 5.99, p < 0.01). Conclusions: IGT was found significantly more frequently only in overweight/obese PCOS subjects in comparison with healthy controls. Copyright (C) 2009 S. Karger AG, Basel
引用
收藏
页码:186 / 190
页数:5
相关论文
共 35 条
[1]  
Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO
[2]  
2-S
[3]   A prospective study of the prevalence of the polycystic ovary syndrome in unselected Caucasian women from Spain [J].
Asunción, M ;
Calvo, RM ;
San Millán, JL ;
Sancho, J ;
Avila, S ;
Escobar-Morreale, HF .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2000, 85 (07) :2434-2438
[4]   The prevalence and features of the polycystic ovary syndrome in an unselected population [J].
Azziz, R ;
Woods, KS ;
Reyna, R ;
Key, TJ ;
Knochenhauer, ES ;
Yildiz, BO .
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2004, 89 (06) :2745-2749
[5]   Ultrasound assessment of the polycystic ovary: international consensus definitions [J].
Balen, AH ;
Laven, JSE ;
Tan, SL ;
Dewailly, D .
HUMAN REPRODUCTION UPDATE, 2003, 9 (06) :505-514
[6]   Low-density lipoprotein receptor-related protein-5 C/T polymorphism in exon 18 is associated with C peptide and proinsulin levels in control women and patients with polycystic ovary syndrome [J].
Bendlova, Bela ;
Vankova, Marketa ;
Zajickova, Katerina ;
Hill, Martin ;
Zemanova, Adela ;
Cibula, David ;
Vejrazkova, Daniela ;
Lukasova, Petra ;
Vcelak, Josef ;
Vondra, Karel ;
Vrbikova, Jana .
FERTILITY AND STERILITY, 2008, 90 (03) :699-708
[7]   OBESITY, FAT DISTRIBUTION, AND WEIGHT-GAIN AS RISK-FACTORS FOR CLINICAL DIABETES IN MEN [J].
CHAN, JM ;
RIMM, EB ;
COLDITZ, GA ;
STAMPFER, MJ ;
WILLETT, WC .
DIABETES CARE, 1994, 17 (09) :961-969
[8]   Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome [J].
Ciampelli, M ;
Fulghesu, AM ;
Cucinelli, F ;
Pavone, V ;
Ronsisvalle, E ;
Guido, M ;
Caruso, A ;
Lanzone, A .
METABOLISM-CLINICAL AND EXPERIMENTAL, 1999, 48 (02) :167-172
[9]   Is insulin resistance an essential component of PCOS? [J].
Cibula, D .
HUMAN REPRODUCTION, 2004, 19 (04) :757-759
[10]   European guidelines on cardiovascular disease prevention in clinical practice:: past, present, and future:: a need for joint forces [J].
Cifkova, Renata ;
Mancia, Giuseppe ;
Kjeldsen, Sverre E. ;
Laurent, Stephane .
JOURNAL OF HYPERTENSION, 2008, 26 (02) :157-160